After making its debut on Canada's NEO Exchange, MindMed made its Nasdaq debut. The mental health wellness company uses psychedelic substances as treatments for patients.
Psychedelics have made tremendous mainstream progress when it comes to the general public understanding the benefits, but Rahn said it's just "early innings for the entire industry and for our company" after becoming the first publicly traded psychedelics treatment company a year ago.
"For many, many years, solutions in the mental health space just really haven't been moving the needle in solving mental health for folks, and so what MindMed is doing is reimagining and reengineering how we are approaching mental health," CEO J.R. Rahn told Cheddar. "But we're doing it through substances like LSD, MDMA, psilocybin, these are psychedelics that from the 1960s were really demonized by society but we see great promise in what we call psychedelic-assisted therapy."
However, while marijuana legalization efforts have been going the route of deregulating for both medical and recreational purposes, Rahn said he doesn't believe the psychedelic industry should take the same path, touting the company's plan on sticking to FDA approval.
"I think the cannabis industry is vastly different than what we're trying to achieve here in the psychedelics medicine industry. There was a lot of mistakes made in cannabis. It's still not federally legal in the United States," he explained. "Our objective is to make these medicines accessible in all 50 states and all at the same time and do that in a scalable manner because 40 percent of the country needs these medicines. I think we are, as a company, going to stay away from legalization efforts and really just focus on the FDA pathway because that is how medicines ultimately get approved in the United States."
However, while he emphasized MindMed's approach through the U.S. government's regulatory framework, Rahn recognized that efforts to legalize and decriminalize psychedelics as the "voice of the people" hoping to find new solutions for mental health conditions.
MindMed trading under the ticker symbol MNMD closed at $4.02 per share on the day.
Chipmaker Nvidia is poised to release a quarterly report that could provide a better sense of whether the stock market has been riding an overhyped artificial intelligence bubble or is being propelled by a technological boom that’s still gathering momentum.
Cracker Barrel said late Tuesday it’s returning to its old logo after critics — including President Donald Trump — protested the company’s plan to modernize.
Low-value imports are losing their duty-free status in the U.S. this week as part of President Donald Trump's agenda for making the nation less dependent on foreign goods. A widely used customs exemption for international shipments worth $800 or less is set to end starting on Friday. Trump already ended the “de minimis” rule for inexpensive items sent from China and Hong Kong, but having to pay import taxes on small parcels from everywhere else likely will be a big change for some small businesses and online shoppers. Purchases that previously entered the U.S. without needing to clear customs will be subject to the origin country’s tariff rate, which can range from 10% to 50%.
Southwest Airlines will soon require plus-size travelers to pay for an extra seat in advance if they can't fit within the armrests of one seat. This change is part of several updates the airline is making. The new rule starts on Jan. 27, the same day Southwest begins assigning seats. Currently, plus-size passengers can pay for an extra seat in advance and later get a refund, or request a free extra seat at the airport. Under the new policy, refunds are still possible but not guaranteed. Southwest said in a statement it is updating policies to prepare for assigned seating next year.
Cracker Barrel is sticking with its new logo. For now. But the chain is also apologizing to fans who were angered when the change was announced last week.
Elon Musk on Monday targeted Apple and OpenAI in an antitrust lawsuit alleging that the iPhone maker and the ChatGPT maker are teaming up to thwart competition in artificial intelligence.
Hear from Gabino & Stephen Roche on Saphyre’s institutional AI platform that centralizes pre‑ and post‑trade data, redefining settlement speed and accuracy.
